ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 569,49
-0,78%
Dow Jones
38 834,86
0,15%
DAX
18 069,48
-0,30%
Brent Oil
84,785
0,00%
Bitcoin
64 828,65
-0,48%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. China Bioligic Products Holdings Inc (CBPO)

  7. China Bioligic Products Holdings Inc (CBPO) Actualités

CBPO

China Bioligic Products (CBPO)

China Bioligic Products Holdings Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CBPO
DateHeureSourceTitreSymboleSociété
03/05/202315h48Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:CBPOChina Bioligic Products Holdings Inc
22/04/202122h24Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CBPOChina Bioligic Products Holdings Inc
21/04/202114h52Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CBPOChina Bioligic Products Holdings Inc
21/04/202114h47Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:CBPOChina Bioligic Products Holdings Inc
20/04/202122h40Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:CBPOChina Bioligic Products Holdings Inc
20/04/202122h30PR Newswire (US)China Biologic Announces Completion of Going Private TransactionNASDAQ:CBPOChina Bioligic Products Holdings Inc
29/03/202123h01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CBPOChina Bioligic Products Holdings Inc
29/03/202122h30PR Newswire (US)China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2020NASDAQ:CBPOChina Bioligic Products Holdings Inc
01/03/202114h00PR Newswire (US)China Biologic Announces Shareholders' Approval of Merger AgreementNASDAQ:CBPOChina Bioligic Products Holdings Inc
25/01/202114h44PR Newswire (US)China Biologic Announces Extraordinary General Meeting of ShareholdersNASDAQ:CBPOChina Bioligic Products Holdings Inc
15/01/202112h28Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CBPOChina Bioligic Products Holdings Inc
24/11/202022h30PR Newswire (US)China Biologic Reports Financial Results for the Third Quarter of 2020NASDAQ:CBPOChina Bioligic Products Holdings Inc
19/11/202014h09PR Newswire (US)China Biologic Enters into Definitive Merger Agreement for Going Private TransactionNASDAQ:CBPOChina Bioligic Products Holdings Inc
13/11/202014h00PR Newswire (US)China Biologic Products to Report Third Quarter 2020 Financial ResultsNASDAQ:CBPOChina Bioligic Products Holdings Inc
17/08/202023h01Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CBPOChina Bioligic Products Holdings Inc
17/08/202022h30PR Newswire (US)China Biologic Reports Financial Results for the Second Quarter of 2020NASDAQ:CBPOChina Bioligic Products Holdings Inc
10/08/202014h00PR Newswire (US)China Biologic Products to Report Second Quarter 2020 Financial ResultsNASDAQ:CBPOChina Bioligic Products Holdings Inc
29/06/202007h00PR Newswire (US)China Biologic Provides Additional Comments on the Xinjiang Deyuan and Shuanglin TransactionNASDAQ:CBPOChina Bioligic Products Holdings Inc
20/05/202022h45PR Newswire (US)China Biologic Comments on the Xinjiang Deyuan and Shuanglin TransactionNASDAQ:CBPOChina Bioligic Products Holdings Inc
20/05/202022h30PR Newswire (US)China Biologic Reports Financial Results for the First Quarter of 2020NASDAQ:CBPOChina Bioligic Products Holdings Inc
12/05/202014h30PR Newswire (US)China Biologic Products to Report First Quarter 2020 Financial ResultsNASDAQ:CBPOChina Bioligic Products Holdings Inc
08/05/202022h36Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CBPOChina Bioligic Products Holdings Inc
12/03/202022h00PR Newswire (US)China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2019NASDAQ:CBPOChina Bioligic Products Holdings Inc
12/03/202021h34Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:CBPOChina Bioligic Products Holdings Inc
03/03/202014h30PR Newswire (US)China Biologic Products to Report Fourth Quarter and Fiscal Year 2019 Financial ResultsNASDAQ:CBPOChina Bioligic Products Holdings Inc
10/12/201920h20Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CBPOChina Bioligic Products Holdings Inc
13/11/201922h43PR Newswire (US)China Biologic Reports Financial Results for the Third Quarter of 2019NASDAQ:CBPOChina Bioligic Products Holdings Inc
04/11/201914h30PR Newswire (US)China Biologic Products to Report Third Quarter 2019 Financial ResultsNASDAQ:CBPOChina Bioligic Products Holdings Inc
17/10/201914h00PR Newswire (US)China Biologic Special Committee Retains Financial Advisor and Legal CounselNASDAQ:CBPOChina Bioligic Products Holdings Inc
24/09/201914h00PR Newswire (US)China Biologic Forms Special Committee to Review "Going Private" ProposalNASDAQ:CBPOChina Bioligic Products Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:CBPO

Dernières Valeurs Consultées

EU
PX1
CAC 40
EU
DG
Vinci
NASDAQ
MSFT
Microsoft
NASDAQ
AMZN
Amazon.com
EU
BN
Danone
SPI
SP500
S&P 500
EU
BEL20
Bel 20
EU
SGO
Cie de SaintGobain
EU
ACA
Credit Agricole
EU
EN
Bouygues
EU
PX4
SBF 120
NYSE
DIS
Walt Disney
NYSE
JPM
JP Morgan Chase
EU
MC
Lvmh Moet Hennessy Louis...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés